Baader Bank set a €49.00 ($56.98) price target on Lanxess (ETR:LXS) in a research note published on Thursday morning. The brokerage currently has a neutral rating on the stock.
LXS has been the topic of a number of other research reports. Morgan Stanley set a €54.00 ($62.79) price target on Lanxess and gave the stock a neutral rating in a report on Tuesday, December 11th. Independent Research set a €48.00 ($55.81) price target on Lanxess and gave the stock a neutral rating in a report on Friday, January 11th. Deutsche Bank set a €70.00 ($81.40) price target on Lanxess and gave the stock a buy rating in a report on Friday, January 11th. DZ Bank reissued a neutral rating on shares of Lanxess in a report on Thursday, November 15th. Finally, Credit Suisse Group set a €55.50 ($64.53) price target on Lanxess and gave the stock a neutral rating in a report on Thursday, January 17th. Three research analysts have rated the stock with a sell rating, twelve have given a hold rating and nine have given a buy rating to the stock. The company currently has a consensus rating of Hold and a consensus target price of €61.66 ($71.70).
Shares of LXS stock opened at €49.24 ($57.26) on Thursday. The stock has a market cap of $4.48 billion and a price-to-earnings ratio of 15.92. Lanxess has a 1 year low of €39.47 ($45.90) and a 1 year high of €72.60 ($84.42). The company has a debt-to-equity ratio of 75.18, a quick ratio of 0.50 and a current ratio of 2.54.
LANXESS Aktiengesellschaft, a specialty chemicals company, develops, manufactures, and markets chemical intermediates, specialty chemicals, and plastics worldwide. It operates in five segments: Advanced Intermediates, Specialty Additives, Performance Chemicals, Engineering Materials, and ARLANXEO. The Advanced Intermediates segment offers high-grade intermediates for the agrochemical and coating industries; fine chemicals as precursors and intermediates for the pharmaceutical, agrochemical, and specialty chemical industries; customer-specific specialties; organometallics; and tire chemicals.
See Also: Short Selling – Explanation For Shorting Stocks
Receive News & Ratings for Lanxess Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lanxess and related companies with MarketBeat.com's FREE daily email newsletter.